Chapter 5 analyzes how academic institutions, government agencies, and the nascent biotechnology industry argued about the legal ownership of recombinant DNA technology in the name of the public interest. It further reconstructs how a small but influential group of government officials and university research administrators introduced a new framework for the commercialization of academic research by linking private ownership and the public interest.
Keywords: recombinant DNA technology; Science; Law; academic patenting; intellectual property; National Institutes of Health; the Bayh-Dole Act; privatization; public interest; commercialization
Chapter. 13121 words. Illustrated.
Subjects: History of Science and Technology
Full text: subscription required